Fulvestrant - a new treatment for postmenopausal women with hormone-sensitive advanced breast cancer.
about
Expression of estrogen-related gene markers in breast cancer tissue predicts aromatase inhibitor responsiveness.Current status and future perspectives in the endocrine treatment of postmenopausal, hormone receptor-positive metastatic breast cancer.Inhibition of estradiol-induced mammary proliferation by dibenzoylmethane through the E2-ER-ERE-dependent pathway.
P2860
Fulvestrant - a new treatment for postmenopausal women with hormone-sensitive advanced breast cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Fulvestrant - a new treatment ...... sitive advanced breast cancer.
@en
type
label
Fulvestrant - a new treatment ...... sitive advanced breast cancer.
@en
prefLabel
Fulvestrant - a new treatment ...... sitive advanced breast cancer.
@en
P2860
P1476
Fulvestrant - a new treatment ...... sitive advanced breast cancer.
@en
P2093
Kurt Possinger
P2860
P304
P356
10.1517/14656566.5.12.2549
P407
P577
2004-12-01T00:00:00Z